Predictive Value of C-Reactive Protein to Albumin Ratio in ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention

The present study aimed to examine the association of C-reactive protein to albumin ratio (CAR) with short-term major adverse cardiac events (MACEs) in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). We included 539 STEMI pati...

Full description

Saved in:
Bibliographic Details
Published in:Angiology 2021-03, Vol.72 (3), p.244-251
Main Authors: Acet, Halit, Güzel, Tuncay, Aslan, Bayram, Isik, Mehmet Ali, Ertas, Faruk, Catalkaya, Sibel
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Biomarkers - blood
C-Reactive Protein - analysis
Female
Humans
Male
Middle Aged
Percutaneous Coronary Intervention - adverse effects
Predictive Value of Tests
Risk Assessment
Risk Factors
Serum Albumin, Human - analysis
ST Elevation Myocardial Infarction - blood
ST Elevation Myocardial Infarction - diagnosis
ST Elevation Myocardial Infarction - therapy
Time Factors
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The present study aimed to examine the association of C-reactive protein to albumin ratio (CAR) with short-term major adverse cardiac events (MACEs) in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). We included 539 STEMI patient treated with pPCI in this study. Patients were divided into 2 groups according to MACE development. Patients with MACE had higher CAR than those without (1.18 [0.29-1.99] vs 0.21 [0.09-0.49], P < .001). Multivariate analysis showed that The Global Record for Acute Coronary Events score, Percutaneous Coronary Intervention with TAXus and cardiac surgery (SYNTAX) score, glucose and CAR (odds ratio:1.326, 95% CI: 1.212-1452, P < .001) were independent predictors of MACE. The CAR may be proven useful for risk stratification in STEMI patients undergoing pPCI.
ISSN:0003-3197
1940-1574
DOI:10.1177/0003319720963697